Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
China
· Delayed Price · Currency is CNY 14.86
-0.04 (-0.27%)
Apr 24, 2025, 2:45 PM CST
Shenzhen YHLO Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jan '21 Jan 1, 2021 | 2019 - 2020 |
| Operating Revenue | 1,992 | 2,018 | 3,930 | 1,134 | 963.01 | Upgrade
|
| Other Revenue | - | 34.69 | 51.13 | 44.37 | 35.99 | Upgrade
|
| Revenue | 1,992 | 2,053 | 3,981 | 1,178 | 999.01 | Upgrade
|
| Revenue Growth (YoY) | -2.99% | -48.42% | 237.96% | 17.91% | 13.87% | Upgrade
|
| Cost of Revenue | - | 949.06 | 1,937 | 530.16 | 433.92 | Upgrade
|
| Gross Profit | 1,992 | 1,104 | 2,044 | 647.73 | 565.09 | Upgrade
|
| Selling, General & Admin | - | 565.36 | 617.71 | 296.87 | 218.31 | Upgrade
|
| Research & Development | - | 314.05 | 238.45 | 129.33 | 101.51 | Upgrade
|
| Other Operating Expenses | 1,684 | 1.57 | 30.2 | 8.09 | -19.9 | Upgrade
|
| Operating Expenses | 1,684 | 888.48 | 897.88 | 436.88 | 301.88 | Upgrade
|
| Operating Income | 307.46 | 215.57 | 1,146 | 210.85 | 263.21 | Upgrade
|
| Interest Expense | - | -6.25 | -8.41 | -11.22 | -13.17 | Upgrade
|
| Interest & Investment Income | - | 132.39 | 14.4 | 8.33 | 1.95 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 3.06 | 9.71 | -2.76 | -5.1 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.64 | -1.59 | -23.65 | -1.14 | -4.69 | Upgrade
|
| EBT Excluding Unusual Items | 305.83 | 343.17 | 1,138 | 204.06 | 242.2 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -32.73 | 54.45 | 0.15 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 2.07 | -3.39 | -0.2 | -0.02 | Upgrade
|
| Asset Writedown | - | -9.08 | -10.33 | - | -1.26 | Upgrade
|
| Other Unusual Items | - | 30.67 | 7.8 | 23.75 | 0.58 | Upgrade
|
| Pretax Income | 305.83 | 334.11 | 1,186 | 227.76 | 241.5 | Upgrade
|
| Income Tax Expense | 4.15 | 54.91 | 165.22 | 23.91 | 33.54 | Upgrade
|
| Earnings From Continuing Operations | 301.67 | 279.2 | 1,021 | 203.85 | 207.96 | Upgrade
|
| Minority Interest in Earnings | - | 75.81 | -9.15 | 0.9 | 2.57 | Upgrade
|
| Net Income | 301.67 | 355.01 | 1,012 | 204.75 | 210.53 | Upgrade
|
| Net Income to Common | 301.67 | 355.01 | 1,012 | 204.75 | 210.53 | Upgrade
|
| Net Income Growth | -15.02% | -64.92% | 394.33% | -2.75% | 95.76% | Upgrade
|
| Shares Outstanding (Basic) | 569 | 564 | 565 | 539 | 508 | Upgrade
|
| Shares Outstanding (Diluted) | 569 | 573 | 569 | 539 | 508 | Upgrade
|
| Shares Change (YoY) | -0.60% | 0.70% | 5.53% | 6.03% | 1.26% | Upgrade
|
| EPS (Basic) | 0.53 | 0.63 | 1.79 | 0.38 | 0.41 | Upgrade
|
| EPS (Diluted) | 0.53 | 0.62 | 1.78 | 0.38 | 0.41 | Upgrade
|
| EPS Growth | -14.52% | -65.17% | 368.42% | -8.28% | 93.33% | Upgrade
|
| Free Cash Flow | - | -735.9 | 1,018 | -113.04 | 92.76 | Upgrade
|
| Free Cash Flow Per Share | - | -1.28 | 1.79 | -0.21 | 0.18 | Upgrade
|
| Dividend Per Share | - | 0.273 | 0.450 | 0.286 | - | Upgrade
|
| Dividend Growth | - | -39.33% | 57.51% | - | - | Upgrade
|
| Gross Margin | 100.00% | 53.77% | 51.34% | 54.99% | 56.56% | Upgrade
|
| Operating Margin | 15.44% | 10.50% | 28.79% | 17.90% | 26.35% | Upgrade
|
| Profit Margin | 15.15% | 17.29% | 25.42% | 17.38% | 21.07% | Upgrade
|
| Free Cash Flow Margin | - | -35.84% | 25.57% | -9.60% | 9.29% | Upgrade
|
| EBITDA | 489.61 | 397.71 | 1,291 | 310.17 | 332.72 | Upgrade
|
| EBITDA Margin | 24.58% | 19.37% | 32.42% | 26.33% | 33.30% | Upgrade
|
| D&A For EBITDA | 182.14 | 182.14 | 144.73 | 99.32 | 69.5 | Upgrade
|
| EBIT | 307.46 | 215.57 | 1,146 | 210.85 | 263.21 | Upgrade
|
| EBIT Margin | 15.44% | 10.50% | 28.79% | 17.90% | 26.35% | Upgrade
|
| Effective Tax Rate | 1.36% | 16.43% | 13.93% | 10.50% | 13.89% | Upgrade
|
| Revenue as Reported | - | 2,053 | 3,981 | 1,178 | - | Upgrade
|
| Advertising Expenses | - | 36.49 | 187.69 | 23.15 | 12.1 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.